Treatment of the rats for a same period (28 days) with C16, a selective non-peptidic ACE2 inhibitor, at a dose that inhibited myocardial ACE2 activity was associated with a significant increase in MI infarct size [65]. This evidence concerns the gene ACE2 and myocardial infarction.